Double-Blind Trial of Ketamine Therapy Plus or Minus Naltrexone in Treatment Resistant Depression (TRD)
Status:
Completed
Trial end date:
2018-02-01
Target enrollment:
Participant gender:
Summary
The primary objective is to determine if the opioid properties of ketamine are responsible
for its antidepressant effects. Since naltrexone can block opiate actions, the investigators
will determine if naltrexone can effectively block ketamine's effects.